CoChat

IMPLICATIONS OF CROSS‐TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN‐LIKE GROWTH FACTOR‐1 SIGNALLING IN SKELETAL MUSCLE

Grounds, Miranda D, Radley, Hannah G, Gebski, Bijanka L, Bogoyevitch, Marie A, Shavlakadze, Thea · 2008 · Clinical and Experimental Pharmacology and Physiology
Cited by 98

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

SUMMARY: Inflammation, particularly the pro‐inflammatory cytokine tumour necrosis factor (TNF), increases necrosis of skeletal muscle. Depletion of inflammatory cells, such as neutrophils, cromolyn blockade of mast cell degranulation or pharmacological blockade of TNF reduces necrosis of dystrophic myofibres in the mdx mouse model of the lethal childhood disease Duchenne muscular dystrophy (DMD). Insulin‐like growth factor‐1 (IGF‐1) is a very important cytokine for maintenance of skeletal muscle mass and the transgenic overexpression of IGF‐1 within muscle cells reduces necrosis of dystrophic myofibres in mdx mice. Thus, IGF‐1 usually has the opposite effect to TNF. Activation of TNF signalling via the c‐Jun N‐terminal kinase (JNK) can inhibit IGF‐1 signalling by phosphorylation and conformational changes in insulin receptor substrate (IRS)‐1 downstream of the IGF‐1 receptor. Such silencing of IGF‐1 signalling in situations where inflammatory cytokines are elevated has many implications for skeletal muscle in vivo. The basis for these interactions between TNF and IGF‐1 is discussed with specific reference to clinical consequences for myofibre necrosis in DMD and also for the wasting (atrophy) of skeletal muscles that occurs in very old people and in cachexia associated with inflammatory disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1681.2007.04868.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 98

Metadata

Authors
Grounds, M. D., Radley, H. G., Gebski, B. L., Bogoyevitch, M. A., & Shavlakadze, T.
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2008-01-21
Volume
35
Issue
7
Pages
846-851
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W1974512256
Cited by
98
References
4
FWCI
3.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IMPLICATIONS OF CROSS‐TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN‐LIKE GROWTH FACTOR‐1 SIGNALLING IN SKELETAL MUSCLE. https://app.cochat.ai/papers/10.1111/j.1440-1681.2007.04868.x
The paper
Grounds, M. D., Radley, H. G., Gebski, B. L., Bogoyevitch, M. A., & Shavlakadze, T. (2008). IMPLICATIONS OF CROSS‐TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN‐LIKE GROWTH FACTOR‐1 SIGNALLING IN SKELETAL MUSCLE. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.2007.04868.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.